TREK-1 (KCNK2 or K 2P 2.1) is a mechanosensitive K 2P channel that is opened by membrane stretch as well as cell swelling. Here, we demonstrate that membrane phospholipids, including PIP 2 , control channel gating and transform TREK-1 into a leak K þ conductance. A carboxy-terminal positively charged cluster is the phospholipid-sensing domain that interacts with the plasma membrane. This region also encompasses the proton sensor E306 that is required for activation of TREK-1 by cytosolic acidosis. Protonation of E306 drastically tightens channel-phospholipid interaction and leads to TREK-1 opening at atmospheric pressure. The TREK-1-phospholipid interaction is critical for channel mechano-, pH i -and voltage-dependent gating.
Introduction
The mammalian K 2P channel subunits have four transmembrane segments and two P domains in tandem that contribute to the K þ -selective ionic pore Patel and Honoré, 2001b; Kim, 2003; Talley et al, 2003; Yost, 2003) . A functional K 2P channel is a dimer of subunits (Lesage et al, 1996; Maingret et al, 2000a; Czirjak and Enyedi, 2001; Lauritzen et al, 2003; Berg et al, 2004; Kang et al, 2004) . Two of the 15 human K 2P subunits, TREK-1 and TREK-2, have particularly interesting functional properties. They form mechanosensitive K þ channels that are activated by membrane stretch as well as cell swelling (Patel et al, 1998; Maingret et al, 1999; Bang et al, 2000; Honoré et al, 2002) . These mechanosensitive K 2P channels are also activated by polyunsaturated fatty acids, including arachidonic acid (AA) and lysophospholipids (Fink et al, 1998; Patel et al, 1998; Maingret et al, 2000b) . TREK-1 and TREK-2 are the targets of an important class of drugs, the volatile general anesthetics Heurteaux et al, 2004) . Moreover, their opening is stimulated by the neuroprotective agent riluzole that is currently used to protect motorneurons in amyotrophic lateral sclerosis (Duprat et al, 2000) . Neurotransmitters and hormones that stimulate the cAMP/PKA pathway strongly inhibit TREK-1 and TREK-2 channel activity (Patel et al, 1998; . Neurotransmitters that stimulate the Gq pathway, such as glutamate, decrease TREK-1 and TREK-2 activity via a direct diacylglycerol (DG) inhibition (Chemin et al, 2003) . Mice in which the TREK-1 channel has been deleted have an increased vulnerability to both epileptic seizure and brain ischemia (Heurteaux et al, 2004) . Moreover, they have lost neuroprotection by polyunsaturated fatty acids and are more resistant to volatile general anesthetics (Heurteaux et al, 2004) .
A particular effort has been made to understand the gating mechanism of the TREK-1 channel (for a review, see Patel et al, 2001 ). The cytosolic carboxy-terminal domain of TREK-1 plays a key role in its function and regulation. A glutamate residue, E306, is a key element in the channel-gating machinery. Its protonation by cytosolic acidification leads to channel activation by drastically changing the pressure dependency in such a way as to render the channel active at atmospheric pressure (Maingret et al, 1999; Honoré et al, 2002) . In the same region, the serine residue S333 is the target of PKA phosphorylation locking the channel in a closed state (Patel et al, 1998) . The TREK-2 channel shares all the functional properties of TREK-1 .
The phospholipid PIP 2 , although a minor component of the plasma membrane, is increasingly recognized as a key physiological regulator of ion channel activity (Hilgemann et al, 2001) . PIP 2 directly activates the inward rectifier IRK potassium channels and is essential for the Gbg-protein activation of GIRK channels (Huang et al, 1998; Mirshahi et al, 2003) . PIP 2 controls nucleotide sensitivity of K ATP channels and promotes channel opening (Baukrowitz et al, 1998; Shyng and Nichols, 1998) . PIP 2 also regulates both activation and inactivation processes of the voltage-gated K þ channels (Loussouarn et al, 2003; Oliver et al, 2004) . Genetic alterations of K þ channel-PIP 2 interactions can lead to channelopathies such as Andersen's and Bartter's syndromes (Lopes et al, 2002) . Receptor-mediated PIP 2 hydrolysis plays a key role in the regulation of several ion channel types (Kobrinsky et al, 2000; Chuang et al, 2001; Runnels et al, 2002; Suh and Hille, 2002; Zhang et al, 2003) and particularly in the inhibition of the TASK channel activity by hormones and neurotransmitters (Czirjak et al, 2001 ). This mechanism is involved in the downmodulation of the TASK-1/-3 K 2P channels by stimulation of Gq-coupled type I metabotropic glutamate receptors (Chemin et al, 2003) .
In the present report, we demonstrate that PIP 2 , but also other membrane phospholipids such as phosphatidyl serine (PS), are essential for TREK-1 channel activity. Phospholipids switch TREK-1 from a voltage-, stretch-and pH-activated channel into a leak K þ conductance. We identify the protein sequence elements that are involved in phospholipid sensing and provide a mechanistic model for channel gating.
Results
Cytosolic PIP 2 stimulates TREK-1 channel activity Both in situ hybridization and immunolocalization studies have shown that striatal neurons express high levels of TREK-1 (Fink et al, 1996; Maingret et al, 2000a; Talley et al, 2001) . In striatal neurons, K þ channels (55.870.9 pS, n ¼ 6; physiological K þ gradient) that are opened by membrane stretch as well as AA were found to be absent in TREK-1 knockout (KO) mice (Heurteaux et al, 2004) . Similarly, cytosolic acidosis as well as PIP 2 stimulate the activity of this endogenous TREK-1 channel ( Figure 1A -C). The single-channel current amplitude measured at 0 mV is not significantly altered by PIP 2 (4.770.3 pA, n ¼ 5 versus 4.970.2 pA, n ¼ 6) and cytosolic acidosis (4.570.25 pA, n ¼ 5, at pH i 5.5), suggesting that NPo is increased in both conditions. Stimulation is maintained after PIP 2 washout ( Figure 1B ). Addition of polylysine (pL) to the intracellular medium, a cationic molecule that is classically used to mask or even remove negatively charged membrane phospholipids such as PIP 2 (Huang et al, 1998; Lopes et al, 2002) , not only reverses PIP 2 stimulation but also inhibits basal channel activity ( Figure  1B and C). This PIP 2 -, pH i -and pL-sensitive 56 pS K þ channel is absent in striatal neurons isolated from TREK-1 KO mice ( Figure 1C ). The same type of findings were obtained with the cloned TREK-1 channel transiently expressed in COS cells. Cytosolic PIP 2 increases TREK-1 channel activity before pL treatment (37/81 patches) and again this effect is only partially reversible upon wash ( Figure 1D ). This PIP 2 /pH i -activated K þ current is absent in EYFP-transfected control COS cells (Supplementary Figure 1B) . Addition of cytosolic pL (30 mg/ml) strongly and irreversibly inhibits basal channel activity (À7872%, n ¼ 10) (Figure 1E and F) . A similar inhibition is observed with the polyamine spermine (100 mM) (À5575%, n ¼ 13) that is also used as a quencher of PIP 2 (Huang et al, 1998) . As expected, pL inhibition is fully reversed by the addition of the anionic molecule heparin (20 mg/ml) (n ¼ 8) that probably removes pL from its interaction with phospholipids (Supplementary Figure 1A and B). As described for the native TREK-1 channel, low concentrations of PIP 2 not only restore the initial basal TREK-1 activity but also actually lead to a higher channel activity (95/95 patches) ( Figure 1E and F). PIP 2 (1 mM) leads to about a two-fold increase in current amplitude as compared to the control condition (n ¼ 10) ( Figure 1F ). Channel stimulation is independent of the level of expression of TREK-1 (5.170.8-fold increase, n ¼ 48, for currents of 200716 pA amplitude and 4.170.7-fold increase, n ¼ 47, for currents of 20887294 pA amplitude). Another addition of pL, after the PIP 2 -induced activation, again inhibits channel activity ( Figure 1E ). Similarly, PIP 2 stimulation is observed in inside-out patches excised from TREK-1-expressing Xenopus oocytes (23/23 patches) (not shown).
PIP 2 regulates TREK-1 gating
The cloned TREK-1 channel activity, like the endogenous striatal channel, is also reversibly stimulated by cytosolic acidification ( Figures 1A, B and 2A) . After a pL treatment that inhibits the basal current, cytosolic acidosis fails to activate TREK-1 (Figure 2A and C). When channel activity is restored (in fact at a higher level) by the addition of PIP 2 , the activating effect of cytosolic acidosis is recovered (n ¼ 18) (Figure 2A-C) . However, the acidic stimulation after PIP 2 addition becomes 'irreversible' and the TREK-1 channel remains locked in a highly active form even when the cytosolic pH is returned to pH 7.2 (n ¼ 18) (Figure 2A-C) . The EC 50 value is estimated to be 125 nM (n ¼ 10). In COS cells, we also occasionally observed inhibition of TREK-1 control currents at higher concentrations of PIP 2 before pL treatment. In (A, B, D and E) inset, the dashed lines indicate the zero current. In (F), the dashed line indicates the control TREK-1 current (empty circles).
When TREK-1 is locked open by PIP 2 , a second cytosolic acidification actually produces a mild current inhibition (À3274%, n ¼ 17) (Figure 2A) , probably related to a decrease in single-channel conductance at low pH i (Maingret et al, 1999) . Again, another addition of pL, after the costimulation with PIP 2 and acidosis, inhibits channel activity, although only partially (n ¼ 12) (Figure 2A) . pL also inhibits stretch activation of TREK-1 and the pressure effect curve is shifted towards more negative pressure values (n ¼ 6) ( Figure 3A-C) . Therefore, TREK-1 channel becomes more resistant to membrane stretch ( Figure 3A and B). With a PIP 2 treatment followed by a cytosolic acidification, the TREK-1 activity is high at atmospheric pressure and pressure stimulation only produces a modest further activating effect (n ¼ 6) (open lock indicated by a star; Figure 3A and B).
TREK-1 is known to display an intrinsic voltage dependency (Bockenhauer et al, 2001; Maylie and Adelman, 2001; Maingret et al, 2002) . The basal TREK-1 current (at atmospheric pressure and at pH i 7.2) is composed of two distinct components : Positive charges in the proximal carboxy-terminal domain of TREK-1 are critically required for PIP 2 stimulation To identify the channel region responsible for PIP 2 stimulation of TREK-1, we generated truncated, chimeric as well as point mutants ( Figure 5A and B). Complete deletion of the amino-terminal domain (DN) does not affect PIP 2 stimulation ( Figure 5A-C) . Similarly, deletion of the last 100 amino acids in the carboxy-terminal domain of TREK-1 (DC100) has no significant effect on PIP 2 effects ( Figure 5A-C) . A complete deletion of the carboxy-terminal domain (DC119) impairs membrane expression as well as channel activity (n ¼ 12) (Supplementary Figure 2A and B) . However, a chimera between the whole carboxy-terminal domain of TASK-3 and the core domain of TREK-1 remains functional and is resistant to PIP 2 ( Figure 5A-C) . Thus, the protein segment of the cytosolic carboxy-terminal domain of TREK-1 upstream of R311 is critical for PIP 2 stimulation ( Figure 5A ). This region is characterized by the presence of several positively charged residues that appear to be excellent candidates for binding PIP 2 ( Figure 5A ). We then engineered an internal deletion in this region (intraDC) (Figure 5A-C) . The intraDC mutant is active and comparable to TREK-1 WT in current amplitude ( Figure 5B ), but, similar to the TREK-1/TASK-3 chimera, is not activated by cytosolic PIP 2 ( Figure 5C ). A systematic substitution of the positively charged amino acids by alanines progressively leads to the suppression of TREK-1 stimulation by PIP 2 (Figure 5A-C) . When all five positive charges are removed simultaneously, the mutant 5 þ A remains active but becomes completely resistant to PIP 2 activation ( Figure 5B and C). Furthermore, it loses its capacity to be definitively locked open after a cytosolic acidic stimulation in the presence of PIP 2 (n ¼ 9). Thus, this cationic cluster is critical for PIP 2 stimulation of TREK-1.
Protonation of E306 increases TREK-1/PIP 2 interaction
The positively charged cluster encompasses the negatively charged proton sensor E306, that is essential for cytosolic acidic stimulation of TREK-1 (Figure 5A ). The E306A mutation mimics the effect of cytosolic acidosis in the stimulation of TREK-1 channel activity . The E306A mutant is constitutively active and undergoes no further activation by cytosolic PIP 2 ( Figure 5A-C) . There are two possible explanations for this observation. The first is that PIP 2 is not required for E306A activity. The second one is that, on the contrary, the replacement of E306 by an alanine has drastically increased the capacity of TREK-1 to bind PIP 2 in such a way that it becomes resistant to pL. Maximal channel inhibition is observed with about 0.3 mg/ml pL for TREK-1 WT, whereas only a small effect is seen for , at pH i 5.5 (filled circles) (n ¼ 17) and following cytosolic acidosis (pH i 5.5) after PIP 2 (5 mM) washout (filled squares) (n ¼ 5). The inset shows TREK-1 outward rectification determined by the ratio of current amplitude measured at À100 and 100 mV in control (pH i 7.2) (n ¼ 34), during cytosolic acidosis (pH i 5.5) (n ¼ 17), following cytosolic acidosis (pH i 5.5) after PIP 2 (5 mM) washout (open lock indicated by a star) (n ¼ 5) and at increasing pressure (n ¼ 16, 17 and 7 for À20, À40 and À60 mmHg, respectively). (C) Effect of membrane stretch (À60 mmHg) on TREK-1 voltage dependency (symmetrical K þ gradient). The holding potential was À80 mV and voltage steps to À140 and 140 mV are illustrated. (D) I-V curves (I st ) were constructed at increasing pressure (indicated in mmHg) (0 mmHg, n ¼ 17; À20 mmHg, n ¼ 16; À40 mmHg, n ¼ 17 and À60 mmHg, n ¼ 10). The inset shows the time dependency of TREK-1 measured at 140 mV and expressed as the ratio of the steady state (I st ) over the initial (I to ) current amplitude in control (pH i 7.2) (n ¼ 34), during cytosolic acidosis (pH i 5.5) (n ¼ 17), following cytosolic acidosis (pH i 5.5) after PIP 2 (5 mM) washout (open lock indicated by a star) (n ¼ 5) and at increasing pressure (n ¼ 16, 17 and 11 for À20, À40 and À60 mmHg, respectively).
E306A under the same conditions ( Figure 6A ). Significant inhibition of the E306A mutant by pL can be observed, but at much higher concentrations (3-30 mg/ml) ( Figure 6A ). Also, while the time constant for TREK-1 WT inhibition by 0.3 mg/ml pL is about 15 s ( Figure 6B and C) , the time constant for inhibition of E306A by 0.3 mg/ml pL is much slower in the range of 45 s ( Figure 6B and C). Since replacing E306 by an alanine is equivalent to protonating this particular glutamate, we would expect to find similar properties for TREK-1 at pH i 5.5. Indeed, TREK-1 WT becomes more resistant to pL inhibition at pH i 5.5 ( Figure 6A-C) . Thus, protonation of the negatively charged residue E306 at cytosolic acidic pH probably increases the affinity of TREK-1 (i.e. of the positively charged cluster) for PIP 2 , making it more resisant to pL inhibition, as also observed for E306A. An alternative explanation is that pL may directly inhibit TREK-1 by interacting with E306. However, the double mutant D100 TREK-1 E306A that is pH i -resistant but remains mechanogated , unlike E306A which is locked open, is also sensitively inhibited by cytosolic pL (À6376% with 0.3 mg/ml pL with a time constant of 17.173.9 s at 0 mV, n ¼ 6), suggesting that this possibility is unlikely. In the DN mutant, the whole amino-terminal domain was deleted (Met was introduced at position 46). In the intraDC mutant, the region between K301 and E306 was deleted. The DC100 mutant was deleted after R311. The DC119 was deleted after I292. In the TREK-1/CtTASK-3 chimera, the whole carboxy-terminal domain of TASK-3 was fused to the core of TREK-1 (position 292). In the R311A mutant, arginine at position 311 is substituted by an alanine. In the 3 þ A mutant R297, K301 and K304 are substituted by an alanine. In the 4 þ A mutant R297, K301, K302 and K304 are substituted by an alanine. In the 5 þ A mutant, R297, K301, K302, K304 and R311 are substituted by an alanine. In the E306A mutant, glutamate at position 306 is substituted by an alanine. In these experiments, inside-out patches were held at 0 mV (physiological K þ gradient). The time constants measured for TREK-1 WT at pH i 5.5 and for E306A at pH i 7.2 are significantly slower (Po0.01) as compared to TREK-1 WT measured at pH i 7.2.
Phospholipid specificity of TREK-1 stimulation
To determine whether PIP 2 is specific in its action on TREK-1, various phospholipids were tested ( Figure 7A-D) . The phospholipid PI that lacks both phosphates on the inositol group similarly stimulates TREK-1 channel activity ( Figure 7A and B). Moreover, PS and PE that do not belong to the phosphoinositide family, but are other inner leaflet phospholipids, also stimulate TREK-1 (n ¼ 16 and 5, respectively) ( Figure 7A-D) . Similar to PIP 2 , the various phospholipids lock TREK-1 in the open conformation during cytosolic acidosis ( Figure 7C and  D) . The presence of a large polar head is not an absolute requirement since PA also produces a strong stimulation of TREK-1 after a previous pL treatment (n ¼ 6) ( Figure 7A and  B) . However, the negative phosphate group at position 3 of the glycerol is critical as DG does not stimulate TREK-1 channel activity (n ¼ 5) ( Figure 7A and B) .
The carboxy-terminal domain of TREK-1 interacts with the plasma membrane
To demonstrate that the carboxy-terminal domain of TREK-1 interacts with the plasma membrane phospholipids, we took advantage of the SOS recruitment strategy in yeast (Aronheim, 2001) . Briefly, the Saccharomyces cerevisiae cdc25-2 strain harbors a temperature-sensitive mutation in its guanyl exchange factor (GEF) cdc25, the yeast homolog of human SOS. This mutation prevents binding of GEF and activation of the small G protein Ras and consequently impairs cell growth at the nonpermissive temperature of 371C ( Figure 8A and B) . However, Ras activation and cell growth occur at the permissive temperature of 251C ( Figure  8A and B). This system can be complemented by expressing the full-length hSOS (Aronheim, 2001) . But, an amino-terminal fragment of hSOS (aa 1-1067) is unable to go to the membrane by itself and thus does not activate Ras ( Figure 8A and B). Plasma membrane targeting of this hSOS deletion can be rescued by fusing it to a membrane-associated protein. Dimerization of Jun was used as a positive control ( Figure 8B ; see Materials and methods). Interestingly, the carboxy-terminal domain of TREK-1 brings the SOS fragment to the plasma membrane and allows cell growth at 371C ( Figure 8A and B) . This result suggests that the cytosolic carboxy-terminal domain of TREK-1 is in close proximity with the plasma membrane. This effect is specific to TREK-1 as the fusion proteins SOS/TASK-1 or SOS/TWIK-2, two other K 2P channels, do not allow growth at 371C ( Figure 8B ). Deletion of the highly charged region (aa 293-307) in the 5 0 end of the carboxy-terminal domain of TREK-1 (DCtTREK-1) impairs growth of transformed cdc25-2 cells at 371C ( Figure 8B) . Substitution of the five positively charged residues required for PIP 2 stimulation by an alanine (5 þ A mutant) similarly impairs cell growth, unlike the E306A mutation ( Figure 8B) .
We next generated a fusion protein between the fluorescent protein EYFP and the carboxy-terminal domain of TREK-1 (EYFP-CtTREK-1). This construct was transiently expressed in COS cells that were either fixed without permeabilization by paraformaldehyde (PFA) or with permeabilization by ethanol ( Figure 8C ). In parallel experiments, COS cells expressing the cytosolic EYFP were fixed under the same conditions. Fixation with permeabilization leads to a loss of the fluorescence signal within less than 20 min in the control EYFP condition. On the contrary, the fluorescence signal remains very intense in the EYFP/CtTREK-1 condition even with a 12 h permeabilization step ( Figure 8C and D) . EYFPCtTREK-1 is expressed at the membrane (visualized by wheat germ agglutinin fluorescence) of ethanol-permeabilized transfected cells ( Figure 8E ). Membrane localization was confirmed with confocal microscopy ( Figure 8F) . Deletion of this carboxy-terminal region in TREK-1 (DC119 TREK-1) impairs membrane localization and consequently channel activity (Supplementary Figure 2) .
Discussion
TREK-1 is a polymodal K þ channel that is opened by both physical and chemical stimulations (Patel and Honoré, 2001a, b; Patel et al, 2001) . The channel has an unusual pharmacology and plays an important role in general anesthesia and neuroprotection (Heurteaux et al, 2004) . TREK-1 is a mechanosensitive ion channel that is modulated by cytosolic acidosis (Patel et al, 1998; Maingret et al, 1999; Honoré et al, 2002) . Cytosolic acidosis shifts the pressureeffect curve of TREK-1 towards more positive pressure values, leading to channel opening at atmospheric pressure (Maingret et al, 1999; Honoré et al, 2002) . Cytosolic acidosis protonates E306 in the proximal carboxy-terminal domain of TREK-1 and is mimicked by the E306A mutation .
In the present report, we demonstrate that both the cloned and endogenous neuronal TREK-1 channels are highly dependent for their activity on membrane phospholipids. The cationic molecules pL and spermine, that have a high affinity for phospholipids, inhibit TREK-1 channel activity at rest, but the activity is restored and even stimulated by PIP 2 ( Figure 9A ). The inhibitory effect of polycationic molecules is thought to be due to the fact that they interact with the negative charges of essential membrane phospholipids, thus removing them from their electrostatic interaction with specific positively charged segments in the channel protein (Huang et al, 1998; Lopes et al, 2002) . In the presence of intracellular pL or other polyamines, TREK-1 remains in an inactive state ( Figure 9A) . We have identified a cluster of five positive charges in the proximal carboxy-terminal domain of TREK-1 that is central to the effect of phospholipids ( Figure 5A ). When the positive charges are deleted, TREK-1 becomes resistant to the activation by PIP 2 . The upmodulation of TREK-1 channel activity by PIP 2 or PA is not additive with AA stimulation (Chemin et al, 2003) . By contrast, in the presence of AA, PA as well as DG inhibit TREK-1 activity (Chemin et al, 2003) . Phospholipases control phospholipid levels. However, unlike the TASK-1/-3 channels, PIP 2 hydrolysis via phosholipase C activation is not involved in TREK-1 inhibition by stimulation of metabotropic glutamate Gqcoupled receptors (Chemin et al, 2003) . Rather, DG that is released after phospholipase C activation directly inhibits TREK-1 (Chemin et al, 2003) .
Using a complementation yeast system designed to assay for membrane-protein interactions (Aronheim, 2001) , we have shown that the carboxy-terminal domain of TREK-1 is in close proximity to the plasma membrane. Moreover, the positive charges in this cluster shown to be essential for PIP 2 action are also crucial for this membrane interaction. These results were confirmed by a fluorescence assay also indicating that the carboxy-terminal domain of TREK-1 is probably closely associated with the plasma membrane.
A model presented in Figure 9 summarizes our results and our mechanistic interpretation concerning the effects of PIP 2 . When the positively charged segment cannot interact with the inner leaflet phospholipids, as for instance in the presence of polyamines, the TREK-1 channel is inactive and no stimulus such as stretch or internal acidification can promote channel activity ( Figure 9A ). When PIP 2 interacts with the positively charged carboxy-terminal segment and inserts in the membrane, the channel becomes partially coupled to the membrane and activable by membrane stretch, depolarization and cytosolic acidification ( Figure 9B ). This model proposes that E306 may play an important regulatory role in the interaction between membrane phospholipids and the carboxy-terminal domain of TREK-1 ( Figure 9B ). When the side chain of E306 is protonated at cytosolic acidic pH, the positively charged character of the corresponding protein segment is increased, favoring a stronger electrostatic interaction with the negative charges of the inner leaflet phospholipid ( Figure 9C ). This interaction is so tight that application of PIP 2 at acidic pH results not only in a very strong stimulation of TREK-1, but also an activity that is maintained even when the cytosolic pH is brought to normal. Channel locking in the open conformation is definitive. The TREK-1 channel becomes constitutively open. The same situation may be created when, instead of being protonated, E306 is replaced by an alanine. Although, TREK-1 becomes more resistant to pL at acidic pH i or when E306, the proton sensor, is substituted by an alanine, it remains to be directly demonstrated that protonation of this residue indeed results in a stronger PIP 2 binding that locks the channel open. TREK-1 changes from a voltage-dependent to a leak mode when it is: (i) stimulated by PIP 2 ; (ii) stimulated by cytosolic acidification; (iii) activated by membrane stretch. There is a tight link between TREK-1 stretch activation and membrane phospholipids. Although PIP 2 is generally considered as the key phospholipid for regulation of many ion channels, we have shown in this work that other inner leaflet phospholipids such as PI, PE or PS can fulfill exactly the same key role for TREK-1 channel gating. In the basal condition, TREK-1 current is made up of a leak component and a voltage-and timedependent component. Since the leak component is more resistant to inhibition by pL, it may therefore correspond to channels that are already fully coupled to the membrane phospholipids and thus locked in the open conformation ( Figure 9C ). The remaining voltage-dependent channels may be in a partially coupled conformation, thus activable by stretch, acidosis and depolarization ( Figure 9B ).
These findings provide a substantially better view of the gating mechanism of the TREK channels that were the first mammalian mechanosensitive ion channels to be cloned. They may also have a more general implication since many other types of mechanically activated ion channels (although most probably belonging to the TRP family of channels; Voets and Nilius, 2003) are known to be essential to sense pressure variations in mammalian cells (Sachs and Morris, 1998; Bode et al, 2001; Hamill and Martinac, 2001; Suchyna et al, 2004) .
Materials and methods

Neuronal cell cultures
Primary culture of mouse striata was carried out as described previously (Heurteaux et al, 2004) . Cells were plated in culture dishes previously coated with polyornithine and 50% fetal calf serum. Culture medium was DMEM (Invitrogen) with glucose (1.5 g/l) for 24 h and then B27 with uridine (2 mM) and 5-fluoro-2 0 -deoxyuridine (2 mM).
Electrophysiological recordings
Patch-clamp measurements of mouse striatal neurons were performed 2 or 3 days after plating. In inside-out configuration the internal solution contained (in mM): 155 KCl, 5 EGTA, 10 HEPES at pH 7.2 with KOH, and the external solution contained (in mM): 120 NaCl, 5 KCl, 3 MgCl 2 , 1 CaCl 2 and 10 HEPES at pH 7.4 with NaOH. Tetra-ethylammonium chloride (10 mM), 3 mM 4-aminopyridine, 10 mM glibenclamide and 5 mM glucose were freshly added and pH adjusted with HCl. For COS cell experiments, culture, mutagenesis, transfection and the electrophysiological procedure have been detailed elsewhere (Patel et al, 1998; Maingret et al, 1999 Maingret et al, , 2002 Honoré et al, 2002) . The long spliced form of mTREK-1, with an extension of 15 amino acids in the amino-terminal domain, was used in the present study (Bockenhauer et al, 2001 ) (mTREK-1 sequence submission). In some experiments, an amino-terminal EYFP-tagged mTREK-1 channel was used and no functional difference with untagged WT channel was observed, including sensitivity to phospholipids. For clarity and consistency with our previous work, amino-acid numbering is related to the short mTREK-1 splice variant (Fink et al, 1996) . We routinely transfected between 0.1 and 0.5 mg DNA per 35 mm diameter plate containing 20 000 cells. The external medium contained (in mM): 150 NaCl, 5 KCl, 3 MgCl 2 , 1 CaCl 2 and 10 HEPES at pH 7.4 with NaOH. To study the voltage dependency of TREK-1, we used an extracellular medium containing (in mM): 155 KCl, 5 EGTA, 5 EDTA and 10 HEPES at pH 7.4 with KOH. The cytosolic medium contained (in mM): 155 KCl, 5 EGTA, 10 HEPES at pH 7.2 with KOH. For Xenopus oocyte patch experiments, we used an extracellular medium containing (in mM): 96 NaCl, 2 KCl, 1 MgCl 2 , 1 CaCl 2 and 5 HEPES at pH 7.4 with NaOH and an internal medium containing (in mM) 96 KCl, 5 EGTA and 10 HEPES at pH 7.2 with KOH. Patch pipettes of about 1.5 Mohm were used for excised inside-out patches. Patches were routinely held at a holding potential of À80 mV and stimulated by voltage ramps of 660 ms in duration from À100 to 100 mV every 5 s. Membrane stretch and cytosolic acidosis were applied as described previously (ALA fast pressure-clamp system) (Patel et al, 1998; Maingret et al, 1999; Honoré et al, 2002) . Phospholipids (Sigma and Biomol TEBU) were dissolved in a mixture of chloroform/methanol/water/HCl (20/10/1/1) at a concentration of 5 mM. Aliquots were kept under argon at À801C. Aliquots were daily evaporated with air and lipids were dissolved in the saline solution that was sonicated on ice for 15 min before use. pL was dissolved in water at a concentration of 30 mg/ml and stored at À201C. Control experiments were carried out using the evaporated solvent alone. The Dunnet ANOVA test was used for statistical analysis. Differences were considered significant at Po0.05.
Yeast experiments
The yeast SOS recruitment strategy (Aronheim, 2001 ) was used to investigate the interaction of the carboxy-terminal domain of TREK-1 with the plasma membrane. We constructed the SOS (aa 1-1067)/ CtTREK-1 (aa 293-411) fusion protein, the SOS/CtTASK-1 (aa 243-394) and the SOS/CtTWIK-2 (aa 244-313). We generated a truncated SOS/DCtTREK-1 mutant (aa 308-411). We introduced the E306A mutation in the SOS/CtTREK-1 as well as the 5 þ A mutant R297, K301, K302, K304 and R311. As a positive control, the following expression vectors were used: pADNS 5 0 SOS (aa 1-1066), JZ (aa 249-331) of c-Jun and pYES2 expresssing a myristilated c-Jun (249-331) (localization to the plasma membrane) (Aronheim, 2001) . In isolation, these plasmids do not allow growth of transformed cdc25-2 cells at 371C. However, when both plasmids are introduced into cdc25-2 cells, growth is obtained at the nonpermissive temperature of 371C because of Jun dimerization. 5 0 SOS is now targeted to the membrane, can bind and activate Ras, thus rescuing cell growth at 371C (Aronheim, 2001) .
Fluorescence experiments
The cytosolic EYFP or the fusion protein EYFP/CtTREK-1 (starting at amino acid 293) was transiently expressed in COS cells as described previously. After 48 h of expression, cells were fixed for 20 min with paraformaldehyde (4% at room temperature) or with ethanol (701 on ice for 3-12 h). During ethanol fixation, cells are rapidly permeabilized. After fixation, cells were stained with fluorescent wheat germ agglutinin (Alexa Fluor-594 conjugated, 3 mg/ml, Molecular Probes) and DAPI (Vector Labs) for 5 min. After mounting, specimens were observed using an epifluorescence microscope (Axioplan 2, Carl Zeiss) equipped with Â 25 and Â 63 oil immersion objectives and appropriate combinations of filters. Images were recorded with a cooled CCD camera (Coolsnap HQ, Photometrics) driven by Metavue software. For confocal microscopy, cells were examined with a scanning laser confocal microscope (Leica) using an Â 100 oil immersion objective. For fluorescence quantification, 20-40 independent fields from two separate experiments have been analyzed per experimental condition. Fluorescence was determined in blind and quantified as either strong, medium or absent. Mean values were normalized to the fluorescence of nonpermeabilized (PFA) EYFP-TREK-1-expressing COS cells. Similar results were obtained with three independent transfections.
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